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Introduction {#sec001}
============

Two-dimensional (2D) echocardiography is currently one of the most practical noninvasive methods to measure cardiac structures for fetuses prenatally and children postnatally. Reference values and Z-scores for fetal cardiac dimensions derived from 2D echocardiography are well-established \[[@pone.0233179.ref001]--[@pone.0233179.ref012]\], allowing quantification and comparison of size of cardiac structures in differing subgroups of a disease \[[@pone.0233179.ref013]\]. In 1990s, several studies on fetal cardiac measurements using B-mode ultrasonography were published, providing regression equations and 95% confidence intervals based on gestational age \[[@pone.0233179.ref001]--[@pone.0233179.ref003]\]. In 2005, Schneider *et al*. reported reference ranges as well as z-scores, not only based on gestational age, but also based on non-cardiac fetal biometric parameters (biparietal diameter and femur length) \[[@pone.0233179.ref006]\]. The computation of z-scores provides more information than just normality, allowing more precise evaluation of the cardiac structure when the measurement is below or above 95% confidence intervals.

In clinical practice, z-scores references are practical not only in the screening and diagnosis of fetal cardiac structural abnormalities \[[@pone.0233179.ref014]--[@pone.0233179.ref018]\], but fetal cardiologist also use z-scores to predict and counsel about possible postnatal outcome and treatment strategies \[[@pone.0233179.ref019]--[@pone.0233179.ref022]\]. However, currently available z-score calculators are based on studies from Caucasian populations. Fetal echocardiographic reference values for the Chinese population had been published, but z-scores were not provided \[[@pone.0233179.ref011]\]. Z-score reference range for normal fetal heart size have been reported in Asian population, but not for specific cardiac structures \[[@pone.0233179.ref009]\]. Our aim was to construct normal ranges and z-scores for fetal cardiac structures, in the 14--38 weeks of gestational period among a Sino-origin population sample.

Materials & methods {#sec002}
===================

A total of 599 healthy pregnant Taiwanese mothers with an estimated gestational age (EGA) from 14 to 38 weeks were enrolled from September 2016 until December 2017. Cases received measurements prospectively at 3 clinics in northern Taiwan from an unselected population. We recruited only women with singleton pregnancies and regular menstruation, and had a measurement of the crown-rump length that confirmed EGA. We include only fetuses without growth restriction based on fetal biometry of the Taiwanese fetuses \[[@pone.0233179.ref023]\].

A total of 24 fetuses were found to be abnormal and excluded. Fetuses were retrospectively excluded if there were any maternal disease diagnosed during the pregnancy or any structural abnormality diagnosed either prenatally or postnatally. Exclusion criterions for abnormality included: small-or large-for-gestational age, nuchal translucency greater than the 95th centile at 11--14 weeks, or any chromosomal/genetic abnormalities. Each subject was studied cross-sectionally in order to avoid potential collinearity bias of including serial measurements of the same fetus. The study was approved by institutional review board of Mackay memorial hospital (16MMHIS041e 20160300003). An informed consent was obtained in written format from every participant before enrollment.

Instrumentation {#sec003}
---------------

Fetal measurements were performed using ProSound Alpha 6 (Hitachi, Tokyo, Japan) and ProSound F75 (Hitachi, Tokyo, Japan). All pregnancies were examined transabdominally with 5.0-MHz probes in the 14--38 week period. Images were recorded digitally and stored securely.

Echocardiography and measurements {#sec004}
---------------------------------

All fetal examinations were performed by an experienced examiner (Szu-Ping Huang), and reviewed by an obstetrician-gynecologist and a pediatric cardiologist. No intra-observer variability was performed. Measurements of fetal heart structures and developmental markers were done according to guidelines for standard imaging planes from the American Society of Echocardiography \[[@pone.0233179.ref024]\]. All measurements were reported in centimeters, with the exception of HA which used centimeters^2^. Heart length (HL), heart width (HW), heart circumference (HtC), heart area (HA), chest circumference (CC) and chamber width were assessed in the four-chamber view in end-diastole with closed atrioventricular valves. HL was measured from base to apex, while HW was measured at the level of the atrioventricular valve. HtC and HA were measured by tracing along the outer border of the heart. CC was measured using ellipse covering the outer borders of the ribs. Width of left atrium (LA), right atrium (RA), left ventricle (LV) and right ventricle (RV) were measured just above or below the atrioventricular valve orifice, at the level where the diameter was largest and when maximal dilatation occurred in end-diastole. In LVOT and RVOT views, diameter of aortic annulus (Ao) and pulmonary annulus (PA) were measured at the level of the valve in diastole (when the valve is closed). In three-vessel-trachea view, we measure transverse aortic isthmus (AI) diameter and transverse ductus arteriosus (DA) diameter at its junction into each other when widest systolic diameter occured. All measurements were made from inner edge to inner edge. Fetal developmental markers including: biparietal diameter (BPD), head circumferences (HdC), abdominal circumference (AC), and femur length (FL) were concurrently measured during the same visit.

Grouping and data management {#sec005}
----------------------------

EGA was binned into 2-week intervals from 14 weeks to 38 weeks gestational age. Thus, a fetus that had received a cardiac measurement at 21 weeks and 6 days would fall in the 21 weeks and 4 days to 23 weeks and 3 days interval and would be grouped in the 22-week gestational age group. Other developmental markers were also binned and derived by ensuring normality of distribution between intervals, as well as optimization of representation in each category. The binned groupings were as follows: bi-parietal distance (BPD) (\<4.5, 4.5--5.4, 5.5--6.4, 6.5--7.4, 7.5--8.4, ≥8.5), femur length (FL) (\<3.5, 3.5--4.4, 4.5--5.4, 5.5--6.4, ≥6.5), abdominal circumference (AC) (\<13, 13.0--14.9, 15.0--16.9, 17.0--18.9, 19.0--20.9, 21.0--22.9, 23.0--24.9, 25.0--26.9, 27.0--28.9, 29.0--30.9, ≥31.0), and head circumference (HdC) (\<15.0, 15.0--16.9, 17.0--18.9, 19.0--20.9, 21.0--22.9, 23.0--24.9, 25.0--26.9, 27.0--28.9, 29.0--30.9, ≥31.0). A Kolmogorov-Smirnov test of normality was conducted to assess normality of distribution in each developmental marker binned group throughout the developmental timeline. If the normality assumption was found to be violated in more than one group, transformations of the cardiac measurement variables was performed to return the distribution to normality. Transformation order was selected based on the Krishnan et al. (2016) paper (y^2^, y^3^, ln(y), √(y), 1/y, 1/y^2^, 1/√(y), 1/y^2^). If the transformations did not improve the normality of the distribution in each group, higher order equations were used to ensure normality was attained.

In order to construct nomograms, fetal heart structure measurements were binned for normality of distribution between binned groupings and for optimization of representation within groups. For simplicity, range notation upper limited was always rounded down. For example, as "5.0 ± 1.0" which denoted a range of 4.0--5.99cm. Whereas "0.1 ± 0.05" would signify a range from 0.05--0.149cm. For heart circumference (HtC) measurements were categorized into 8 groups (\<4.0, 5.0±1.0, 7.0±1.0, 9.0±1.0, 11.0±1.0, 13±1.0, 15±1.0, ≥16.0). Other fetal heart structure binned categorizations can be found in the supplementary figures.

Statistics {#sec006}
----------

In order to illustrate overall distribution of cases throughout the gestational age, we compared our sample distribution to past studies along the gestational age range. Our sample was compared to two studies done by Shapiro et al. (1998) \[[@pone.0233179.ref003]\] and Krishnan et al. (2016) \[[@pone.0233179.ref010]\] by case distribution because both represent important studies on fetal heart biometry that had used similar parameters and markers as our study. A 2-sample Kolmogorov-Smirnov test was employed to compare if the distributions were significantly different in distribution.

Best fitting equations were obtained by use of best-fit model selection method. Linear, quadratic and cubic models were tested and selected by the following criteria: minimizing Akaike's Information Criteria (AIC) and root mean squared error (RMSE). Adjusted R-squared values allowed for comparisons between developmental marker models for each fetal cardiac structure. Furthermore, centile graphs for each fetal heart measurement by each developmental marker (EGA, BPD, FL, AC, and HdC) were provided. Mean regression lines, as well as the 95% CI (2.5^th^ and 97.5^th^ percentile lines) were plotted and compared by heart structures for each developmental marker.

Lastly, nomograms were developed for all 13 fetal heart structures and each developmental marker. Nomograms are a helpful tool to establish z-score when developmental markers and fetal heart measurement are obtained. To construct the nomograms, a method developed by Schneider et al. was followed (2005). All measurements were transformed with by natural log transformation, as indicated by previous paper. Z-scores were obtained using the following formula: $$Z - score = \left( ln\left( actual \right) - ln\left( predicted \right) \right)/root\mspace{720mu} MSE$$

Z-scores were obtained by stratifying by developmental markers. The z-scores were then plotted using the XLStat package's scatter plot with regression lines function. All other statistical analyses were performed using SPSS V22.0.

Results {#sec007}
=======

A total 575 normal healthy fetuses were included in our sample. The sample distribution was compared to the sample distribution in past studies by Shapiro et al. \[[@pone.0233179.ref003]\] ([Fig 1a](#pone.0233179.g001){ref-type="fig"}) and Krishnan et al. \[[@pone.0233179.ref010]\] ([Fig 1b](#pone.0233179.g001){ref-type="fig"}) for each EGA group from 14--38. Shapiro et al. had more cases in earlier EGA pregnancies, while our sample had a relatively equal distribution of study subjects based on gestation age. A 2-sample Kolmogorov-Smirnov test of distribution equality showed that we had a significantly different distribution from that of Shapiro et al. *(d-stat = 0*.*355 \> d-critical = 0*.*082; p\<0*.*001)*, and to the more recent study by Krishnan et al. *(d-stat = 0*.*223 \> d-critical = 0*.*149; p\<0*.*001)*.

![**a, b.** Distribution of cases compared to past studies with normal ranges for heart structures.](pone.0233179.g001){#pone.0233179.g001}

The best fitting equations for the 13 fetal heart structures were reported by each developmental marker ([Table 1](#pone.0233179.t001){ref-type="table"}). A forward best-fitting model was used to determine the optimal model. All model selection resulted in linear models being selected as those that minimized AIC and RMSE, except for the transverse arteries: Transverse Aortic Isthmus by EGA (*AI* = -0.18\**EGA*^2^ + 1.97\**EGA* + 0.28) and Transverse Ductus Arteriosus by FL (*DA* = -0.13\**FL*^2^ + 1.31\**FL* + 0.32). Our findings indicate that EGA was the optimal marker for: HW (adj. R^2^ = 0.928), HL (adj. R^2^ = 0.939), HtC (adj. R^2^ = 0.948), HA (adj. R^2^ = 0.972), CC (adj. R^2^ = 0.964), LV (adj. R^2^ = 0.848), Ao (adj. R^2^ = 0.859), and AI (Quadratic: adj. R^2^ = 0.749). On the other hand, HdC was an optimal marker for: ln(LA) (adj. R^2^ = 0.858), RA (adj. R^2^ = 0.878), ln(RV) (adj. R^2^: EGA = estimated gestational age, BPD = bi-parietal distance, FL = femur length, AC = abdominal circumference, HC = head circumference†EGA = estimated gestational age, BPD = bi-parietal distance, FL = femur length, AC = abdominal circumference, HC = head circumference.

10.1371/journal.pone.0233179.t001

###### Best fitting models for each fetal heart structures.

![](pone.0233179.t001){#pone.0233179.t001g}

  Structures[^a^](#t001fn002){ref-type="table-fn"}   Markers                                    n     Transformed   Best Fit Model   Best Fitting Equation                 Adj.-R^2^   AIC       RMSE
  -------------------------------------------------- ------------------------------------------ ----- ------------- ---------------- ------------------------------------- ----------- --------- -------
  Heart Width                                        EGA[\*](#t001fn001){ref-type="table-fn"}   575   None          Linear           HW = 0.12\*EGA---0.76                 0.928       -1622.8   0.243
                                                     BPD                                        508   None          Linear           HW = 0.45\*BPD---0.95                 0.868       -1240.4   0.294
                                                     FL                                         508   None          Linear           HW = 0.58\*FL + 0.94                  0.856       -1196.6   0.307
                                                     AC                                         508   None          Linear           HW = 0.25\*AC + 1.06                  0.903       -1397.8   0.252
                                                     HdC                                        508   None          Linear           HW = 0.26\*HdC + 0.86                 0.897       -1365.3   0.260
  Heart Length                                       EGA[\*](#t001fn001){ref-type="table-fn"}   574   None          Linear           HL = 0.16\*EGA---0.96                 0.939       -1437.7   0.285
                                                     BPD                                        507   None          Linear           HL = 0.57\*BPD + 1.23                 0.878       -1027.8   0.362
                                                     FL                                         507   None          Linear           HL = 0.74\*FL---1.22                  0.870       -996.1    0.374
                                                     AC                                         507   None          Linear           HL = 0.32\*AC---1.38                  0.910       -1184.6   0.310
                                                     HdC                                        507   None          Linear           HL = 0.33\*HdC + 1.13                 0.904       -1153.4   0.320
  Heart Circumference                                EGA[\*](#t001fn001){ref-type="table-fn"}   575   None          Linear           HtC = 0.49\*EGA---2.64                0.948       -255.3    0.800
                                                     BPD                                        508   None          Linear           HtC = 1.73\*BPD -1.07                 0.891       19.1      1.017
                                                     FL                                         508   Natural-Log   Linear           ln(HtC) = 0.23\*FL + 1.17             0.841       -2066.9   0.131
                                                     AC                                         508   None          Linear           HtC = 0.39\*AC---0.37                 0.929       -198.6    0.821
                                                     HdC                                        508   None          Linear           HtC = 0.51\*HdC---2.28                0.929       -198.6    0.821
  Heart Area                                         EGA[\*](#t001fn001){ref-type="table-fn"}   575   None          Linear           HA = 0.65\*EGA---9.22                 0.972       287.1     1.281
                                                     BPD                                        508   Natural-Log   Linear           ln(HA) = 0.36\*BPD---0.49             0.878       -1500.9   0.228
                                                     FL                                         508   Natural-Log   Linear           ln(HA) = 0.46\*FL + 0.59              0.851       -1400.8   0.251
                                                     AC                                         508   Natural-Log   Linear           ln(HA) = 0.20\*AC---0.69              0.903       -1617.0   0.203
                                                     HdC                                        508   None          Linear           HA = 1.42\*HdC---1.18                 0.889       395.0     1.472
  Chest Circumference                                EGA[\*](#t001fn001){ref-type="table-fn"}   575   None          Linear           CC = 0.81\*EGA---3.12                 0.964       111.1     1.100
                                                     BPD                                        508   None          Linear           CC = 2.89\*BPD + 8.09                 0.927       314.4     1.360
                                                     FL                                         508   None          Linear           CC = 3.71\*FL + 8.10                  0.901       468.2     1.582
                                                     AC                                         508   None          Linear           CC = 1.63\*AC + 8.87                  0.952       101.5     1.103
                                                     HdC                                        508   None          Linear           CC = 1.67\*HdC + 7.61                 0.951       121.1     1.124
  Left Atrium                                        EGA                                        534   None          Linear           LA = 0.04\*EGA---0.30                 0.849       -2268.1   0.119
                                                     BPD                                        508   None          Linear           LA = 0.15\*BPD + 0.30                 0.789       -2011.2   0.138
                                                     FL                                         508   None          Linear           LA = 0.20\*FL + 0.29                  0.795       -2025.3   0.136
                                                     AC                                         508   None          Linear           LA = 0.09\*AC + 0.33                  0.841       -2153.7   0.120
                                                     HdC[\*](#t001fn001){ref-type="table-fn"}   508   Natural-Log   Linear           ln(LA) = 0.05\*HdC---1.59             0.858       -2046.3   0.133
  Right Atrium                                       EGA                                        534   None          Linear           RA = 0.05\*EGA---0.38                 0.875       -2200.5   0.127
                                                     BPD                                        508   None          Linear           RA = 0.19\*BPD + 0.33                 0.841       -2000.2   0.139
                                                     FL                                         508   None          Linear           RA = 0.24\*FL + 0.33                  0.828       -1959.9   0.145
                                                     AC                                         508   None          Linear           RA = 0.10\*AC + 0.38                  0.866       -2089.0   0.128
                                                     HdC[\*](#t001fn001){ref-type="table-fn"}   508   None          Linear           RA = 0.11\*HdC + 0.29                 0.878       -2126.8   0.122
  Left Ventricle                                     EGA[\*](#t001fn001){ref-type="table-fn"}   534   None          Linear           LV = 0.04\*EGA---0.23                 0.848       -2381.6   0.107
                                                     BPD                                        508   None          Linear           LV = 0.14\*BPD + 0.31                 0.783       -2114.3   0.125
                                                     FL                                         508   None          Linear           LV = 0.18\*FL + 0.30                  0.795       -2133.8   0.121
                                                     AC                                         508   None          Linear           LV = 0.08\*AC + 0.35                  0.828       -2231.4   0.111
                                                     HdC                                        508   None          Linear           LV = 0.08\*HdC + 0.29                 0.817       -2200.0   0.114
  Right Ventricle                                    EGA                                        534   None          Linear           RV = 0.04\*EGA---0.29                 0.884       -2414.9   0.104
                                                     BPD                                        508   None          Linear           RV = 0.16\*BPD + 0.32                 0.841       -2160.6   0.118
                                                     FL                                         508   None          Linear           RV = 0.21\*FL + 0.32                  0.834       -2137.7   0.121
                                                     AC                                         508   Natural-Log   Linear           ln(RV) = 0.10\*AC---0.79              0.857       -2045.6   0.133
                                                     HdC[\*](#t001fn001){ref-type="table-fn"}   508   Natural-Log   Linear           ln(RV) = 0.11\*HdC---0.89             0.889       -2173.1   0.118
  Aortic Annulus                                     EGA[\*](#t001fn001){ref-type="table-fn"}   494   None          Linear           Ao = 0.02\*EGA---0.13                 0.859       -2843.9   0.056
                                                     BPD                                        482   None          Linear           Ao = 0.08\*BPD + 0.19                 0.811       -2641.0   0.064
                                                     FL                                         482   Natural-Log   Linear           ln(Ao) = 0.22\*FL---1.35              0.804       -1929.9   0.135
                                                     AC                                         482   None          Linear           Ao = 0.04\*AC + 0.21                  0.841       -2723.3   0.059
                                                     HdC                                        482   None          Linear           Ao = 0.05\*HdC + 0.17                 0.828       -2688.3   0.061
  Pulmonary Annulus                                  EGA                                        494   Natural-Log   Linear           ln(PA) = 0.04\*EGA---1.81             0.782       -1937.0   0.140
                                                     BPD                                        482   None          Linear           PA = 0.08\*BPD + 0.26                 0.796       -2539.4   0.072
                                                     FL                                         482   None          Linear           PA = 0.11\*FL + 0.26                  0.801       -2552.4   0.071
                                                     AC                                         482   None          Linear           PA = 0.05\*AC + 0.28                  0.818       -2594.8   0.068
                                                     HdC[\*](#t001fn001){ref-type="table-fn"}   482   None          Linear           PA = 0.05\*HdC + 0.22                 0.829       -2626.3   0.065
  Transverse Aortic Isthmus                          EGA[\*](#t001fn001){ref-type="table-fn"}   494   None          Quadratic        AI = -0.18\*EGA2 + 1.97\*EGA + 0.28   0.749       -3239.1   0.038
                                                     BPD                                        482   None          Linear           AI = 0.03\*BPD + 0.15                 0.711       -3102.8   0.040
                                                     FL                                         482   Inverse       Linear           1/AI = -0.64\*FL + 5.37               0.681       -585.9    0.543
                                                     AC                                         482   Squared       Linear           AI2 = 0.01\*AC + 0.01                 0.709       -3559.9   0.025
                                                     HdC                                        482   None          Linear           AI = 0.02\*HdC + 0.14                 0.739       -3154.5   0.038
  Transverse Ductus Arteriosus                       EGA                                        494   Natural-Log   Linear           ln(DA) = 0.03\*EGA---2.16             0.674       -1914.3   0.002
                                                     BPD                                        482   None          Linear           DA = 0.03\*BPD + 0.17                 0.659       -3038.5   0.043
                                                     FL                                         482   None          Quadratic        DA = -0.13\*FL2 + 1.31\*FL + 0.32     0.678       -3064.0   0.041
                                                     AC                                         482   None          Linear           DA = 0.02\*AC + 0.18                  0.679       -3067.5   0.041
                                                     HdC[\*](#t001fn001){ref-type="table-fn"}   482   None          Linear           DA = 0.02\*HdC + 0.16                 0.685       -3076.7   0.041

\*Forward stepwise selection criteria for 0.01 for model selection was utilized.

^a.^ RMSE = root mean squared error;

^b.^AIC = Akaike's Information Criteria

^†^EGA = estimated gestational age, BPD = bi-parietal distance, FL = femur length, AC = abdominal circumference, HC = head circumference

Centile graph tracking development of heart circumference by EGA, BPD, FL, AC and HdC were plotted and reported in [Fig 2](#pone.0233179.g002){ref-type="fig"}. Centile graphs of other fetal heart structures can be found in Supplementary Materials ([S1a--S1m Fig](#pone.0233179.s001){ref-type="supplementary-material"}).

![Centile graphs for heart circumference by estimated gestational age, bi-parietal distance, femur length, abdominal circumference, head circumference.](pone.0233179.g002){#pone.0233179.g002}

Lastly, nomograms were developed for HtC from the knowledge of each developmental marker ([Fig 3](#pone.0233179.g003){ref-type="fig"}). The nomograms are useful tools for physicians to quickly assess z-score of a certain heart structure according to developmental marker measurements. Nomograms for all other fetal heart structures can be found in the Supplementary Materials section ([S2a--S2m Fig](#pone.0233179.s002){ref-type="supplementary-material"}).

![Nomogram for heart circumference by estimated gestational age, bi-parietal distance, femur length, abdominal circumference, head circumference.](pone.0233179.g003){#pone.0233179.g003}

Discussion {#sec008}
==========

We present regression equations, centile graphs and nomograms for 13 fetal echocardiographic measurements from 14 to 38 weeks in Taiwanese sample, allowing calculation of z-scores for these cardiac structures in fetal life from knowledge of EGA, BPD, FL, AC, and HdC. Although reference ranges of fetal cardiac measurements in an Asian population has been published previously \[[@pone.0233179.ref011]\], our study is the first to provide nomogram representation in an Asian population and with a full range of developmental markers. In addition, the sample selection was collected with even distribution throughout the gestational age. We employed a standardized selection criteria for model selection, which resulted in linear model selection for most structures. Furthermore, estimated gestational age and head circumference were shown to be the best markers for predicting fetal cardiac growth.

A strict inclusion and exclusion criteria ensured that developmental reference ranges were based on normal cases that were normally distributed or transformed if the normality distribution assumption was violated. Fetuses aged 14--38 weeks comprised our sample, with a relatively equal distribution of study subjects based on gestational age. Selection of cardiac structure development were done by comparing linear, quadratic and cubic models. Most structures resulted in a linear model selection. In a review by Devore \[[@pone.0233179.ref025]\], equality of frequency between different developmental ages was a necessary item for ensuring quality of centile and z-score values derived from the sample. This is a feature of our sample which ensured representativeness of fetal growth throughout pregnancy. In other published studies on reference range of fetal echocardiography \[[@pone.0233179.ref003], [@pone.0233179.ref010]\], data were mainly collected during the second trimester, with fewer cases in each third-trimester gestational weeks (n\<10). The under-representation in later EGA of past studies, may have produced models that were under-sampled at later developmental stages resulting in higher order best-fitting equations that were not necessarily the most suitable models for "normal" development. Our data provides a balanced gestational sample that can provide more accurate summary throughout all cardiac gestational development ages.

When comparing correlation of fetal heart growth to other developmental markers, each fetal heart measurement is generally correlated with estimated gestational age (EGA). In detail, gross heart size (HW, HL, HtC, HA, and CC), LV, Ao, AI were best correlated to estimated gestational age, while LA, RA, RV, PA, and DA appeared to be better correlated with HdC. In fetal circulation, the majority of the cardiac output is carried out by right ventricle, while left ventricular output supplies blood flow to fetal brain \[[@pone.0233179.ref026]\]. Thus, left heart structures may theoretically be better correlated with fetal head growth. However, our data suggests the opposite. This paradoxical finding implies that head growth is not solely affected by size of left heart. In summary, fetal heart growth is generally well-correlated with gestational age or head circumferences. For certain fetal heart structures, head circumferences can be used as a developmental marker to aid in predicting fetal heart growth.

A review of recent cardiac developmental nomograms providing guidance on developing nomograms indicates that cardiac development in fetuses has been shown to vary between races\[[@pone.0233179.ref027]\], indicating the need for developing accurate centiles and nomograms that reflect Asian cardiac development. When comparing the centile graphs of RV and LV by EGA (See Supplementary Materials, [S1h & S1i Fig](#pone.0233179.s001){ref-type="supplementary-material"}) to those of Shapiro et al\[[@pone.0233179.ref003]\] from Israel, and Gabbay-Benziv et al\[[@pone.0233179.ref028]\] from the United States, our best fit lines were both linear, while RV and LV were higher order equations in both the other studies. Despite this difference, the range of development by EGA followed a similar trend to ours in earlier development, however the range of normality tended to be wider at later stages of development. The mean width for LV was slightly lower, for example, at 33 weeks gestation, the mean LV dimensions was 1.09cm compared to 1.36cm from the American population and 1.15cm in the Israeli population. We produced centile graphs and nomograms that were similar to the American study by Krishnan et al \[[@pone.0233179.ref010]\]and the Canadian study by Schneider et al\[[@pone.0233179.ref006]\] for Ao, PA by EGA, BPD and FL. Our normal ranges (See Supplementary Materials, [S1j & S1k Fig](#pone.0233179.s001){ref-type="supplementary-material"}) had a similar trend for Ao and PA by BPD, with a slightly lower range of normality at earlier ages, but a higher rate of development at later developmental stages. The difference in development pattern in our sample may suggest the need for consideration of race when comparing fetal cardiac development.

Compared to nomogram z-score calculations from previous fetal cardiac nomogram studies \[[@pone.0233179.ref006]--[@pone.0233179.ref008], [@pone.0233179.ref029], [@pone.0233179.ref030]\], using the same parameters reported by Cantinotti et al (*Developmental markers*: EGA = 28 week, FL = 5.2 cm, BPD = 7.2 cm and Ao = 0.35cm, AI = 0.2)\[[@pone.0233179.ref027]\], our nomograms produced the following z-scores for Ao (GA: z = -2.30, FL: z = -3.42, and BPD: z = -2.42). Our calculations for Ao fell mid-range compared to the calculations by nomograms from previous studies (Ranges: GA: -3.97 \~ -1.83; FL: -4.04 \~ -1.1; BPD: -3.77 \~ -1.58), and were further from normal development for EGA, FL, and BPD, compared to Krishnan et al., Schneider et al. and McElhinney et al., but were closer to normal development than Lee et al. and Pasquini et al. Moreover, we produced nomograms with the same methodology and parameter (Ao\*FL, LV\*FL, PA\*FL, RV\*FL, Ao\*GA, PA\*GA) as Schneider et al \[[@pone.0233179.ref006]\] as well a variety of other parameters that were not included. Although our nomograms followed a similar trend in development, the normal growth curves were shifted left on the x-axis, indicating that development was occurring at a slower rate in our sample than in the Caucasian sample. We hope to share our best fitting equations and nomograms online on mobile apps and websites that measure fetal echocardiography development (eg. parameterz.com, BabyNorm, etc.) \[[@pone.0233179.ref031]\], to supplement previously developed nomograms and provide novel nomograms for parameters that have not yet been reported. Our measurements could be easily accessible to both patients and physicians alike who are need to compare their measurements among an Asian sample.

Limitations {#sec009}
-----------

There are a few possible limitations. Developmental normality was determined during the neonatal period and thus some genetic syndromes or chromosomal abnormalities may have been missed during the neonatal stage. First, although our sample was more evenly distributed throughout the gestational period, our sample is relatively small compared to some previous Caucasian studies \[[@pone.0233179.ref008], [@pone.0233179.ref012]\]. A further larger scale study to validate current finding may be necessary in a Taiwanese sample. Second, measurements may have been influenced by intra-observer bias, since only one ultrasound observer collected data. Despite this limitation the observer was an experienced operator, and therefore measurement errors were less likely to be present, however interpretation of the findings should be kept in mind, as the reference ranges likely did not account for inexperienced operator error, as well as failing to capture inter-observer variability. Third, our sample may be confounded by the fact that sampling was done from an unselected and non-randomized population, participants attending the 3 clinics may have confounding factors that were not accounted for and thus may have influenced the reference ranges. Fourth, our sample include cases conceived by assisted reproductive technologies (ART). The use of ART may have an impact on the fetal heart, although the mechanism may be confounded by intrauterine growth restriction and factors related to causes of infertility \[[@pone.0233179.ref032]\]. As we prospectively exclude cases with growth restriction, the proportion of ART cases in our sample were 4%, which was similar to general population in Taiwan \[[@pone.0233179.ref033]\]. Despite concerns about the effect of ART, our sample may represent the heterogenicity of fetal heart growth in Asian fetus without growth restriction. Lastly, some helpful measurements are not included, for example, ventricular thickness, diameters of bilateral peripheral pulmonary arteries and diameter of aortic isthmus in sagittal view.

Conclusions {#sec010}
===========

The challenge of prenatally diagnosing congenital heart disease is not to diagnose the condition itself, but rather to predict the fetal or post-natal outcomes based on reference ranges and to select cases that may benefit from fetal intervention, where available. Nomograms are practical to use in clinical practice for quick and manual calculations of z-scores for guiding clinical decisions, which is not yet sufficiently established for fetal development in an Asian population. Since there is significant geographical differences in the birth prevalence of CHD worldwide, using reference ranges developed from specific racial populations would be more suitable in confirming normal fetal cardiac development.

Supporting information {#sec011}
======================

###### 

a-m. Centile graphs by estimated gestational age, bi-parietal distance, femur length, abdominal circumference, head circumference.

(PDF)

###### 

Click here for additional data file.

###### 

a-m. Nomogram for estimated gestational age, bi-parietal distance, femur length, abdominal circumference, head circumference.

(PDF)

###### 

Click here for additional data file.

###### 

(XLSX)

###### 

Click here for additional data file.

Assistance in statistical computation and visualization was provided by Chan-Yu Sung, a research fellow from Taiji Clinic was greatly appreciated.
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• No comprehensive fetal assessment was performed including estimated fetal weight assessment. Fetal growth restricted fetuses (under the 10th percentile) shouldn't be included in nomograms' construction as they may present cardiac remodelling (Rodríguez-López M, UOG 2017).

• Atrial measurement should be performed at its maximal distension (end-systole) JS Carvalho UOG 2013.

• No inter or intraobserver variability was studied.

• There is no data available on the feasilibity of the studied parameters.
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Responses to the Reviewers

Reviewer \#1: The article is nice, well written, good statistical analysis. There a few points that merit attention:

1\) In the method sections and in the tables is not really clear how measurements are made and what they represent (eg. Left atrium, right atrium, right ventricle are not measurements, specify what you measure and insert units, millimeter, cmq or what else). Please specify well. I would add a table on how measurements have been performed.

Thank you for the suggestion. We have specified how the measurement was made more clearly in Lines 80-95. Units of measurements were explicitly stated as using cm and cm2. In summary, we measured heart & chest size, chamber width, aortic annulus (Ao) and pulmonary annulus (PA) in diastole, while measured transverse aortic isthmus (AI) and transverse ductus arteriosus (DA) in its widest systolic diameter. We chose to measure Ao and PA annulus in diastole but not in systole, in order to optimize measurement especially in earlier gestational age. Our measurement dimensions were established based on past studies measuring Ao and PA annulus during diastole (Sharland et al., 1992; Shapiro et al., 1998; Trisha V. Vigneswaran et al., 2018).

2\) A comparison with other nomograms would be very important. Are the range of normality higher or lower than those previously proposed mainly based on Caucasian population?

In this context discuss and cite also Cantinotti et al. Limitations of Current Fetal Echocardiography Nomograms for 2D Measures: A Critical Overview and Analysis for Future Research. J Am Soc Echocardiogr. 2018 Dec;31(12):1368-1372.e10.

Thank you for providing this suggestion and references for support. We have added two new paragraph that add to the discussion section with a comparison between centile graphs and nomograms from our findings to this paper and other previous studies (Lines 247-280).

3\) These nomograms may be incorporated in current web site providng nomograms (e. parameterz) and mobile App (such as BabyNorm). Please comment and cite at this aim.

Cantinotti et al. Pediatric echocardiographic nomograms: What has been done and what still needs to be done.Trends Cardiovasc Med. 2017 Jul;27(5):336-349.

Thank you for sharing these resources. We have included a section in the conclusion and added the following text to our discussion (Lines 280-286):

"We hope to share our best fitting equations and nomograms online on mobile apps and websites that measure fetal echocardiography development (eg. parameterz.com, BabyNorm, etc.)(Cantinotti et al, 2017), to supplement previously developed nomograms and provide novel nomograms for parameters that have not yet been reported. Our measurements could be easily accessible to both patients and physicians alike who are need to compare their measurements among an Asian sample"

4\) Some helpful measurements are missing such as ventricular thickness. Please add in the limitations.

We have added the missing parameters as limitations in our study (Lines 310-312).

5\) Limitations and Conclusive remarks should be separate by discussion, please add subtitles

Thank you to the reviewer for this point. We have added subheadings for Limitation and Conclusion section (Line 288 & Line 314).

Reviewer \#2: This is a well-designed prospective study done in a low risk population including almost 600 cases to define normal ranges (Z-scores) of different echocardiographic variables.

The strengths of the paper include:

\- reasonable sample size across the range of gestational age.

\- clearly defined methodology.

\- The authors have used both gestational age and different fetal biometries to base their normal ranges on.

-Extensive documentation is provided with graphs representing 5th and 95th percentiles

However, several issues should be addressed:

Abstract:

Results section in the abstract should be reduced

Thank you to the reviewer for his feedback on the abstract. We have shortened the abstract, especially the results section.

Methodology:

• No baseline characteristics are included such as use of assisted reproductive techniques or maternal diabetes which may have an impact on the fetal heart (Valenzuela-Alcaraz B, Circulation 2013; Patey O, UOG 2019).

We retrospectively excluded cases with any maternal disease diagnosed during pregnancy, including GDM and cases of growth restriction in later pregnancy or small for gestational age at birth. The proportion of ART cases in our sample is 4%, which is similar to general population in Taiwan (4.3%) (Hsu JC, Su YC, Tang BY, Lu CY). Use of assisted reproductive technologies before and after the Artificial Reproduction Act in Taiwan. PloS one. 2018;13(11):e0206208). We believe our sample may represent the heterogenicity of fetal heart growth in Asian fetus without growth restriction. However, for clarity we have added a new paragraph in the limitation section illustrating the issue of including ART cases in our sample (Lines 303-310).

• No comprehensive fetal assessment was performed including estimated fetal weight assessment. Fetal growth restricted fetuses (under the 10th percentile) shouldn't be included in nomograms' construction as they may present cardiac remodelling (Rodríguez-López M, UOG 2017).

We prospectively excluded any fetuses that had FGR so they would not have impacted our sample, and only represented normally developed fetuses. We have clarified the inclusion & exclusion criteria in method section and added reference of the fetal biometry we used (Line 56-57).

• Atrial measurement should be performed at its maximal distension (end-systole) JS Carvalho UOG 2013.

Thank you for feedback on this point. Atrial size in end-systole represents the largest diameter of atrium in cardiac cycle. However, we chose to measure in diastole, which is the same as Shapiro et al., 1998, and also hope to provide a reference with simple measuring process.

No inter or intraobserver variability was studied.

This is indeed a limitation of our study, since we only had one sonographer, interobserver variability was not studied. However, to ensure quality of measurement and assessment, all measurements were confirmed by an obstetrician-gynecologist and a pediatric cardiologist during patient visits. We have explained this in both method and limitation sections (Line 76-78 & line 295-300).

• There is no data available on the feasibility of the studied parameters.

Thank you for the feedback. We have added reference 14-22 in the introduction section to justify the description about feasibility of the studied parameters. (Line 39-42):" In clinical practice, z-scores references are practical not only in the screening and diagnosis of fetal cardiac structural abnormalities (reference 14-18), but fetal cardiologist also use z-scores to predict and counsel about possible postnatal outcome and treatment strategies (reference 19-22)."

• Discussion should be reduced.

Thank you for your feedback on the discussion section. We have shortened the discussion section for parts that were repeating and have rearranged some sections for clarity and conciseness.

• There is no consistent data to state that "For cases with uncertain gestational age, head circumference could be used as an optimal developmental marker to predict fetal heart growth" in line 347-349

We have revised this statement to now state, "For certain fetal heart structures head circumferences can be used as a developmental marker to aid in predicting fetal heart growth." (Line 245-246)
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